Ambu A/S (OTCMKTS:AMBBY – Get Free Report) is one of 665 publicly-traded companies in the “Holding & other investment offices” industry, but how does it compare to its peers? We will compare Ambu A/S to related companies based on the strength of its analyst recommendations, dividends, valuation, profitability, earnings, risk and institutional ownership.
Profitability
This table compares Ambu A/S and its peers’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Ambu A/S | 7.23% | 6.80% | 5.32% |
Ambu A/S Competitors | -24.81% | -46.30% | -1.24% |
Earnings and Valuation
This table compares Ambu A/S and its peers gross revenue, earnings per share and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Ambu A/S | $684.73 million | $24.09 million | 95.85 |
Ambu A/S Competitors | $1.13 billion | $84.16 million | 48.77 |
Analyst Ratings
This is a summary of current recommendations for Ambu A/S and its peers, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Ambu A/S | 0 | 0 | 1 | 0 | 3.00 |
Ambu A/S Competitors | 126 | 559 | 858 | 14 | 2.49 |
As a group, “Holding & other investment offices” companies have a potential upside of 72.33%. Given Ambu A/S’s peers higher possible upside, analysts plainly believe Ambu A/S has less favorable growth aspects than its peers.
Insider & Institutional Ownership
54.3% of shares of all “Holding & other investment offices” companies are held by institutional investors. 25.6% of shares of all “Holding & other investment offices” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
About Ambu A/S
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. The company was founded in 1937 and is headquartered in Ballerup, Denmark.
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.